Last edition
News about "Drug substance manufacturing"
Evonik Invests USD 100 Million to Expand US Drug Manufacturing
Evonik is investing USD 100 million to upgrade its US drug substance Contract Development and Manufacturing (CDMO) facility, expanding manufacturing capacity to meet growing demand for US-based pharmaceutical outsourcing.
Drug Substance Manufacturing | 10/07/2026 | By News Bureau
PharmAla Completes GMP Manufacturing for ALA-002
PharmAla has completed GMP manufacturing of ALA-002 drug substance components and is preparing to begin GMP drug product manufacturing for upcoming global clinical trials.
Drug Substance Manufacturing | 07/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy